Source Of Anticancer Drugs Research Articles

Yemeni medicinal plants as a source of anticancer drugs: A review

Yemeni medicinal plants as a source of anticancer drugs: A review

Phytochemical profiling and anticancer potential of Memecylon lushingtonii Gamble methanolic crude extracts

The present investigation examines the anticancer characteristics of phytochemicals derived from Memecylon lushingtonii Gamble (MLG) leaves, concentrating on their efficiency against breast cancer cell lines. Utilising column chromatography, we recovered four different fractions from the methanol extract of MLG leaves. The fourth fraction, rich in bioactive chemicals, displayed substantial cytotoxicity in MTT experiments against MCF-7 cells, indicating powerful anticancer potential. Further investigations revealed a varied array of phytochemicals, including phenols and flavonoids, recognised for their medicinal properties. This discovery emphasises the promise of MLG leaf extracts as a source of anticancer drugs and establishes the framework for further investigations into their mechanisms of action.

In Vitro Screening of Anticancer Activity and Phytochemical of Connarus Wightii Medicinal Plant

Due to the rising death rate from cancer worldwide, it is one of the biggest worries. Globally, medicinal plants have a significant impact on people's health. According to recent research, on the phytochemical analysis of medicinal plant in southern Tamilnadu, particularly in the southwest portion of the Kanayakumari district Thus, the primary goal of this study was to identify the phytochemical compounds, antioxidant properties and anti-cancer properties of medicinal plant connarus wightii. An analysis was conducted on the phytochemical make up of these extracts (chloroform, ethanol, and methanol). Additionally, the extracts from these plants were assessed for their anti-cancer properties. The most prevalent phytochemical components in the plants under investigation were found to be phenols, flavonoids, saponins, glycosides etc, According to recent research, plant extracts have anticancer action of connarus wightii As the result of anticancer investigation using the MTT assay, the test samples, chloroform, ethanol, and methanol extracts of connarus wightii , were strongly cytotoxic to human liver cancer (HepG2) cells with low IC50 values of 99.91, 158.12, and 47.42 µg/ml, respectively. They had an IC50 of less than 10 μg/ml against the cancer cell lines was investigated. This low IC50 suggests that crude extracts have potential as an anticancer drug. The significance of these identified plant species as a source of anticancer drugs was therefore emphasised by the current investigation.

Integrated Transcriptomics and Metabolomics Analysis Reveal Anthocyanin Biosynthesis for Petal Color Formation in Catharanthus roseus

Catharanthus roseus exhibits vibrant petals and displays robust resistance to disease and drought, making it highly valuable for ornamental and gardening applications. While the application of C. roseus as a source of anticancer drugs has gained considerable attention in recent years, there has been limited investigation into the regulatory mechanism underlying anthocyanin accumulation in the petals of C. roseus. This study comprehensively analyzed the metabolome and transcriptome of three distinct C. roseus varieties exhibiting different petal colors. Out of the 39 identified flavonoids, 10 anthocyanins exhibited significant variations in accumulation, directly contributing to the diverse coloration of C. roseus petals. Among them, malvidin 3-O-glucoside and petunidin 3-O-glucoside were identified as primary contributors to the purple petal phenotype, while peonidin 3-O-glucoside and delphinidin 3-O-glucoside exhibited the highest contribution rates to the red petals. Additionally, the variation content of cyanidin 3-O-rutinoside, delphinidin 3-O-glucoside, and petunidin 3-O-rutinoside also influenced the color transformation of C. roseus petals. RNA sequencing identified a total of 4173 differentially expressed genes (DEGs), including 1003 overlapping DEGs. A combined transcriptome and metabolome analysis showed that the coordinately regulated anthocyanin biosynthetic genes including chalcone isomerase (CHS), flavonoid 3′-hydroxylase (F3′H), and dihydroflavonol 4-reductase (DFR) played critical roles in the formation of the anthocyanins. MYB and bHLH transcription factors were also found to be significantly correlated with differences in flower color. These results serve as a foundation for future investigations into anthocyanin biosynthesis and regulatory mechanisms in C. roseus.

Natural Products/Bioactive Compounds as a Source of Anticancer Drugs.

Cancer is one of the major deadly diseases globally. The alarming rise in the mortality rate due to this disease attracks attention towards discovering potent anticancer agents to overcome its mortality rate. The discovery of novel and effective anticancer agents from natural sources has been the main point of interest in pharmaceutical research because of attractive natural therapeutic agents with an immense chemical diversity in species of animals, plants, and microorganisms. More than 60% of contemporary anticancer drugs, in one form or another, have originated from natural sources. Plants and microbial species are chosen based on their composition, ecology, phytochemical, and ethnopharmacological properties. Plants and their derivatives have played a significant role in producing effective anticancer agents. Some plant derivatives include vincristine, vinblastine, irinotecan, topotecan, etoposide, podophyllotoxin, and paclitaxel. Based on their particular activity, a number of other plant-derived bioactive compounds are in the clinical development phase against cancer, such as gimatecan, elomotecan, etc. Additionally, the conjugation of natural compounds with anti-cancerous drugs, or some polymeric carriers particularly targeted to epitopes on the site of interest to tumors, can generate effective targeted treatment therapies. Cognizance from such pharmaceutical research studies would yield alternative drug development strategies through natural sources which could be economical, more reliable, and safe to use.

Some plant metabolites from Petasítes sp. and their effect on cancer cells motility in vitro.

e15077 Background: Plant metabolites are traditionally a valuable source of anticancer drugs. The huge variety of molecular structures found in plants makes it possible to isolate substances that possess not only antimitotic, but also anti-migratory properties on cancer cells. The objective of this study was to evaluate the anti-migratory activity of selected metabolites from Petasítes sp. plants. Methods: Cells of cancer cell cultures PC3 (prostate cancer), A431 (skin cancer), CaCo-2 (colorectal cancer), HeLa (cervical cancer) and T98G (glioma) were seeded in an amount of 15*104 cells per well of a 24-well plate (Biofil, China) in DMEM medium (Gibco, USA) supplemented with 10% FBS (HyClone, USA). After cell adhesion the test substances at a concentration of 40 µM were added, and a wound healing assay was performed according to the standard procedure. The study included the following metabolites: 1) substance 1 (S1) - 2,4-dihydroxy-2,5-dimethylfuran-3(2H)-one; 2) substance 2 (S2) - 5-(hydroxymethyl)furan-2-carbaldehyde; 3) substance 3 (S3) - corynan. The wound area was measured using a Lionheart FX imager (BioTek, USA) at starting time point and after 48 hours of cultivation. Data are presented as mean±95% confidence interval (n = 12). Results: The studied cultures were found to be differently sensitive to the tested substances. Cells of CaCo-2 and PC3 cultures did not demonstrate a significant decrease in mobility, as the degree of scratch overgrowth did not decrease compared to the control without the addition of substances (α = 0.05, df = 22) in all variants of the experiment. However, the A431 skin cancer culture showed reduced motility in all three trials compared to the no-substance control. Namely, the wound area reduction was 81.52 ± 9.6% in the control, 63.77 ± 8.4% in S1 variant, 62.42 ± 6.3% in S2 variant, and 12.05 ± 7.1% in S3 variant. Also, a slowdown in cell motility was observed in HeLa (28.92±5.1% compared to 37.0±6.3% in control) and T98G cells (82.41±9.1% compared to with 97.35±1.9% in control) when incubated with S1. Taking into account the correction for multiple comparisons, only the results for A431 turned out to be significant, but the results obtained for HeLa and T98G cultures were not significant at a corrected significance level (α = 0.003, df = 22). Conclusions: Further studies of 2,4-dihydroxy-2,5-dimethylfuran-3(2H)-one anti-migratory properties are of particular interest, since it showed promising results in three of the five studied cancer cell cultures.

Anticancer Properties of Strobilanthes crispus: A Review

Cancer is a major cause of death worldwide, as exemplified by millions of cancer diagnoses every year. The use of chemotherapy in treating cancer has many disadvantages which include recurrence of cancer, associated with drug resistance, and severe side effects that are harmful to the patients. A better source of anticancer drugs can come from nature. Strobilanthes crispus (S. crispus) is a herbal medicinal plant that is indigenous in Madagascar and the Malay Archipelago. The plant possesses high vitamin and mineral content as well as phytochemicals—like phenols, catechins, tannins, and flavonoids—that are known to have therapeutic effects. Numerous preclinical studies have reported very versatile pharmacological effects of this plant, such as anticancer, antimicrobial, antioxidant, anti-angiogenesis, anti-diabetes, anti-ulcerogenic, and wound healing. Herein, this paper reviews the anticancer properties of S. crispus, providing information for future research and further exploration.

Potential of Anti-Cancer Activity of Secondary Metabolic Products from Marine Fungi.

The promising feature of the fungi from the marine environment as a source for anticancer agents belongs to the fungal ability to produce several compounds and enzymes which contribute effectively against the cancer cells growth. L-asparaginase acts by degrading the asparagine which is the main substance of cancer cells. Moreover, the compounds produced during the secondary metabolic process acts by changing the cell morphology and DNA fragmentation leading to apoptosis of the cancer cells. The current review has analyed the available information on the anticancer activity of the fungi based on the data extracted from the Scopus database. The systematic and bibliometric analysis revealed many of the properties available for the fungi to be the best candidate as a source of anticancer drugs. Doxorubicin, actinomycin, and flavonoids are among the primary chemical drug used for cancer treatment. In comparison, the most anticancer compounds producing fungi are Aspergillus niger, A. fumigatus A. oryzae, A. flavus, A. versicolor, A. terreus, Penicillium citrinum, P. chrysogenum, and P. polonicum and have been used for investigating the anticancer activity against the uterine cervix, pancreatic cancer, ovary, breast, colon, and colorectal cancer.

Targets and Mechanism of Action of Chemical constituents from Plants with Potential Anti-leukemic Activity

The plant kingdom has been the most significant source of anticancer drugs. These include alkaloids, diterpenes, tannins, phenolics, lignans, glycosides which have exhibited lesser toxicity than conventional drugs. In leukaemia, the human body is susceptible to infections due to the replacement of normal leucocytes replaced by a large number of immature cells. Chemotherapy for leukaemia is associated with side effects and drug resistance by the leukemic cells. Cytotoxic agents with higher efficacy and lesser side effects are good candidates in cancer therapy, and plant metabolites serve as potential bioactive agents in anticancer drug formulations. This review article discusses the anti-leukemic properties of compounds obtained from plants and the mechanism of anti-leukemic activity induced by each of these plants. Effect of plants and their metabolites on different leukemic cell lines such as HL60, Kasumi-1, CCRF-CEM, K-562, U-937, THP-1 and MOLT-3 was compared. The findings showed anti-leukemic activity through cell cycle arrest, DNA damage, destruction of mitochondrial function, suppression of tumour genes, apoptosis-inducing enzymes and cytotoxic activities of plants and their derivatives. Based on extensive research findings from this review, phytochemicals and their derived analogues possess the most promising option for the better and less toxic anti-leukemic treatment. Identification of the mechanism of action by the plant bioactive compounds helps in developing standard herbal medicines for effective leukaemia treatment.

Natural Products and Synthetic Analogs as a Source of Antitumor Drugs.

Cancer is a heterogeneous disease and one of the major issues of health concern, especially for the public health system globally. Nature is a source of anticancer drugs with abundant pool of diverse chemicals and pharmacologically active compounds. In recent decade, some natural products and synthetic analogs have been investigated for the cancer treatment. This article presents the utilization of natural products as a source of antitumor drugs.

MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells.

Plants are important sources of biologically active compounds and they provide unlimited opportunities for the discovery and development of new drug leads, including new chemotherapeutics. Miconidin acetate (MA) is a hydroquinone derivative isolated from E. hiemalis. In this study we demonstrated that MA was cytotoxic against acute leukemia (AL), solid tumor cells and cancer stem cells, with the strongest effect exhibited against AL. Furthermore, it was non-cytotoxic against non-tumor cells and did not cause significant hemolysis. MA blocks the G2/M phase and causes cytostatic effects, acting in a similar way to dexamethasone by increasing PML expression. The compound also triggered intrinsic and extrinsic apoptosis by modulating Bax, FasR and survivin expression. This led to an extensive mitochondrial damage that resulted in AIF, cytochrome c and endonuclease G release, caspase-3 and PARP cleavage and DNA fragmentation. We have further demonstrated that MA was strongly cytotoxic against neoplastic cells collected from patients with different AL subtypes. Interestingly, MA increased the cytotoxic effect of chemotherapeutics cytarabine and vincristine. This study indicates that MA may be a new agent for AL and highlights its potential as a new source of anticancer drugs. Graphical abstract MA blocks G2/M phase with PML expression and KI67 inhibition, ROS generation and intrinsic and extrinsic apoptosis, leading to mitochondrial damage, caspase 3 and PARP cleavage and DNA fragmentation.

Comparative Evaluation of the Anti-cancer Activities of the Crude Extracts of Four Nigerian Chewing Sticks

Chewing sticks are commonly used as oral hygiene tool in Nigeria to prevent different types of oral disease including periodontal disease and dental caries. A link has recently been established between periodontal disease and various types of cancers, including lung and breast cancer. The crude extracts of four Nigerian chewing sticks (Fagara zanthoxyloides, Butyrospermum paradoxum, Distemonanthus benthamianus and Nauclea latifolia) were investigated for anticancer activities against four cancer cell lines (Lung A549, Prostate PC-3, Lung NCI-H322, Breast T47D) using Sulforhodamine B (SRB) assay. The result of this study showed that the extracts inhibited the growth of the cells with F. zanthoxyloides having the highest broad spectrum activity against the four cell lines with growth inhibition of 72 %, 71 %, 79 % and 79 % against Lung A549, Prostate PC-3, Lung NCI-H322 and Breast T47D respectively followed by Nauclea latifolia which had a percentage growth inhibition of 70 %, 62 % and 54 % against Lung NCI-H322, Lung A549 and Breast T47D cells lines while showing a weak inhibition of 23 % against Prostate PC-3 cell lines. Butyrospermum paradoxum had the least activity with growth inhibition of 46 %, 56 %, 45 % and 39 % against Lung A549, Prostate PC-3, Lung NCI-H322 and Breast T47D cells lines respectively. D. benthamianus showed selective activity with growth inhibition of 62 %, 34 %, 30 % and 52 % against Lung A549, Prostate PC-3, Lung NCI-H322 and Breast T47D cell lines respectively. The result therefore justifies the use of these plants in traditional medicine and also demonstrates that F. zanthoxyloides could be a good source of anti-cancer drugs.

The In Vitro and In Vivo Anticancer Properties of Moringa oleifera.

Moringa oleifera, a fast-growing deciduous tree that is widely cultivated in tropical and subtropical regions of the world, is well known for its abundant uses. The tree is a source of food, shelter, and traditional medicine for many people, especially in developing countries. Many studies have been conducted to evaluate the various claims of traditional medicine practitioners that the moringa tree can improve health and treat various diseases. The tree has a high nutritional profile, especially the nutrient rich leaves. Some reports also support the use of parts of the tree to reduce blood sugar and cholesterol levels. These attractive properties have led researchers to look for other novel uses for the moringa tree, especially as a source of anticancer drugs. Researchers have tested extracts from various parts of the moringa tree both in vitro and in vivo on several types of cancers with varying success. This review explores the state of current research on the anticancer properties of M. oleifera.

Nature is the best source of anticancer drugs: Indexing natural products for their anticancer bioactivity.

Cancer is considered one of the primary diseases that cause morbidity and mortality in millions of people worldwide and due to its prevalence, there is undoubtedly an unmet need to discover novel anticancer drugs. However, the traditional process of drug discovery and development is lengthy and expensive, so the application of in silico techniques and optimization algorithms in drug discovery projects can provide a solution, saving time and costs. A set of 617 approved anticancer drugs, constituting the active domain, and a set of 2,892 natural products, constituting the inactive domain, were employed to build predictive models and to index natural products for their anticancer bioactivity. Using the iterative stochastic elimination optimization technique, we obtained a highly discriminative and robust model, with an area under the curve of 0.95. Twelve natural products that scored highly as potential anticancer drug candidates are disclosed. Searching the scientific literature revealed that few of those molecules (Neoechinulin, Colchicine, and Piperolactam) have already been experimentally screened for their anticancer activity and found active. The other phytochemicals await evaluation for their anticancerous activity in wet lab.

Curcuma Species: A Source of Anticancer Drugs

Curcuma Species: A Source of Anticancer Drugs

Anticancer Activity and Phenolic Compounds of Pistacia atlantica Extract

Recently a lot of studies have been conducted to identify natural compounds for prevention of the development and recurrence of cancers. The present study aimed to determine phytochemical content and anti proliferative activity of Pistacia atlantica extract. Ethanolic extract of Pistacia atlantica was prepared. The antioxidant activity, total phenol, flavonoid and flavonol content of the extract were evaluated. Cytotoxicity activity of extract on AGS and HeLa cell lines was evaluated by MTT assay 48 hours after treatment. The antioxidant activity of extract was 4.6±0.66 µg/ml while it was 25.41±1.89 µg/ml for butylated hydroxytoluene (BHT). The total phenol, flavonoid and flavonol contents were 269 mg GAE/g, 40.7 mg RUT/g and 88.12 mg RUT/g, respectively. The extract inhibited the proliferation of AGS, HeLa and HDFs cells with IC50 values of 382.3 μg/m, 332.3 μg/ml and 896.3, respectively. This study revealed that the extract of Pistacia atlantica can suppress the proliferation of gastric carcinoma and cervical cancer cells. The plant with high phytoconstituents could be a promising source of anticancer drugs. Key Words: Pistacia atlantica, Cancer, Antioxidant, Proliferation

EVALUATION OF ANTICANCER POTENTIAL OF EIGHT VEGETAL SPECIES FROM THE STATE OF OAXACA.

Background:Eight plant species from Oaxaca, some of them used in traditional medicine, were subjected to screening of several biological activities to provide data regarding their anticancer potential, although no scientific information is available about their pharmacological effects.Materials and methods:Methanol extracts from stems or roots of the eight plants were tested for antioxidant activity by the DPPH- method. Antimicrobial activity was determined using the agar diffusion method and the minimal inhibitory concentration (MIC) was obtained by broth dilution method. Antitopoisomerase activity was assessed using mutant strains of Saccharomyces cerevisiae JN362a, JN394, JN394t-1, JN394t2.4 and JN394t2-5. The mutagenic activity was evaluated using the Ames test (Salmonella typhimurium TA1535).Results:No extract showed significant antioxidant activity. The best antimicrobial activity was observed for Salpianthus arenarius (MIC 56.25 μg/mL) and Lantana achyranthifolia (MIC 78.12 μg/mL) against Staphylococcus aureus. Extracts of Acalypha cuspidata, Alloispermum integrifolium and L. achyranthifolia stems showed antitopoisomerase II activity with JN394t-1 growth of -30.88±0.0%, -38.11±4.95%, and -70.97±12.02% respectively. Galium mexicanum stem extract showed antitopoisomerase I activity with growth of 35.31±6.36% on the same mutant strain. All plant extracts were non-mutagenic. Fractionation of A. cuspidata extract led to identification of two subfractions with antitopoisomerase I and II activity at 154μg/mL (Positive controls 50 and 100μg/mL).Conclusion:Methanol extracts of A. cuspidata, A. integrifolium, G. mexicanum, and L. achyranthifolia stems showed antitopoisomerase and non-mutagenic activities, and consequently could be promising as a source of anticancer drugs.

Marine environment: A potential source for anticancer drugs

Marine environment is known for its rich and vast diversity of flora and fauna. It acts as a potential source for a variety of drugs that can cure wide range of diseases like cancer, diabetes. In this article, we have emphasized on the different types of anticancer drugs obtained from the marine biome. The drugs have been tabulated on the basis of their source. Though most of the drugs are being isolated from marine animals, marine microbes and plants also have the capacity to produce metabolites that possess anticancer activities. This review throws light on some of the anticancer drugs isolated from marine microbes, animals and plants as well. When compared to other natural environments, marine environment tops the list by giving most of the drugs to the medical field. The marine environment has become an extraordinary source for extracting anti-cancer drugs. All these drugs have enough potential to be analyzed for their anti-cancer capabilities. This article highlights all the major marine mined drugs which are being used in treating cancer. Few of these drugs are into existence but few are still under clinical trials. Lots of research needs to be put into this field so as to obtain effective anticancer drugs.

Bioactivity and Cytotoxic Effect of Cyanobacterial Toxin Against Hepatocellular Carcinoma

Cyanobacteria from exotic niches represent a rich resource of a wide array of unique bioactive compounds that are largely under explored, and proving to be potent source of anticancer drugs. A filamentous non-heterocystous isolate was identified by light microscopy and molecular methods using 23S rDNA as a marker was found to belong to Plectonema genus of Cyanobacteria. Organic extract of different cyanobacterial isolates was screened for their cytotoxicity against hepatocellular carcinoma cell line (HepG2). Extracts of (Cyanothece sp.) and (Plectonema terebrans) were found to have the most cytotoxic effect as they caused cell growth inhibition with IC50 value of 13.3% and 8.3% respectively. The cell viability, cell cycle analysis and caspase3 activity were measured. The cell viability of (Cyanothece sp.) and (Plectonema terebrans) showed high reduced (66.7% 57.4% respectively) compared with untreated cells (6.6%). Cell cycle analysis results showed significant arrest in G0/G1 and G2/M phases in the cells treated with Cyanothece sp recorded (52.8%, 0.33%) respectively, low percentage in 2n phase recorded (46.4%), while cells treated with Plectonema terebrans showed (G0/G1 recorded 63.3% and G2/M recorded 0.3 and 2n recorded 35.6%) compared to control which showed relative accumulation of cells in G0/G1 and G2/M recorded (7.38% and 0.13%) respectively and aggressive accumulation of cells in 2n phase recorded (91.8%). Also, Caspase-3 activity increased in the cells treated with Cyanothece sp with highest activity at concentration 13.3% recorded 0.397 ± SD 0.02 and Plectonema terebrans with highest activity at concentration 4% recorded 0.402 ± SD 0.002 and with significant (p<0.05) compared to untreated cells (0.157 ± SD 0.05 nM/mL). These results indicated that two extracts of Cyanobacteria have a promising agent against hepatocellular carcinoma.

Diversity of Nonribosomal Peptide Synthetase Genes in the AnticancerProducing Actinomycetes Isolated from Marine Sediment in Indonesia

Marine actinomycetes is a group of bacteria that is highly potential in producing novel bioactivecompound. It has unique characteristics and is different from other terrestrial ones. Extreme environmentalcondition is suspected to lead marine actinomycetes produce different types of bioactive compoundfound previously. The aim of this study was to explore the presence and diversity of NRPS genes in 14anticancer-producing actinomycetes isolated from marine sediment in Indonesia. PCR amplificationand restriction fragment analysis of NRPS genes with HaeIII from 14 marine actinomycetes were doneto assess the diversity of NRPS genes. Genome mining of one species of marine actinomycetes (strainGMY01) also was employed towards this goal. The result showed that NRPS gene sequence diversity in 14marine actinomycetes could be divided into 4 groups based on NRPS gene restriction patterns. Analysisof 16S rRNA gene sequences of representatives from each group showed that all isolates belong to genusof Streptomyces. Genome mining result showed that strain GMY01 harboring 10 different NRPS geneclusters that encode secondary metabolites, as pure NRPS or hybrid between NRPS and other compounds.These results indicated that marine actinomycetes having a high potential to be developed as source ofanticancer drugs development.